Targeting TNK2/ACK1 reverses the immunosuppressive tumor microenvironment and synergizes with immunochemotherapy in pancreatic cancer

Journal:

Nature Communications

Published:

2025-12-06

DOI:

10.1038/s41467-025-67197-3

Affiliations:

12

Authors:

25

Go to article

Institutions	Authors	Share
Tianjin Medical University Cancer Institute and Hospital, TMU, China	16.333333 16.333333	0.65
State Key Laboratory of Druggability Evaluation and Systematic Translational Medicine, China	4.000000	0.16
The Fifth Affiliated Hospital, SYSU, China	1.000000	0.04
Children's Hospital of Chongqing Medical University (CHCMU), China	1.000000	0.04
School of Medicine, NKU, China	1.000000	0.04
Wake Forest University (WFU), United States of America (USA)	0.833333	0.03
Atrium Health Wake Forest, United States of America (USA)	0.833333	0.03

Interested in Oncology and Carcinogenesis?